COQ5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.030200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.214800E-01
Normal-vs-Stage2
2.506600E-01
Normal-vs-Stage3
2.544000E-02
Normal-vs-Stage4
2.355800E-01
Stage1-vs-Stage2
2.086600E-01
Stage1-vs-Stage3
1.501860E-02
Stage1-vs-Stage4
3.917000E-01
Stage2-vs-Stage3
2.155800E-02
Stage2-vs-Stage4
8.622400E-01
Stage3-vs-Stage4
2.022500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.435000E-01
Normal-vs-AfricanAmerican
1.505640E-01
Normal-vs-Asian
7.880400E-02
Caucasian-vs-AfricanAmerican
4.196200E-01
Caucasian-vs-Asian
2.276600E-01
AfricanAmerican-vs-Asian
9.226800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.463400E-01
Normal-vs-Female
2.539600E-01
Male-vs-Female
6.875600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.592000E-01
Normal-vs-Age(41-60Yrs)
5.707400E-01
Normal-vs-Age(61-80Yrs)
1.681620E-01
Normal-vs-Age(81-100Yrs)
7.104400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.239200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.911800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.985800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.080350E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.863600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.836200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.464420E-01
Normal-vs-Daily Drinker
4.032000E-01
Normal-vs-Weekly Drinker
1.991170E-01
Normal-vs-Occasional Drinker
9.896600E-01
Normal-vs-Social Drinker
5.872400E-01
Non Drinker-vs-Daily Drinker
5.258000E-01
Non Drinker-vs-Weekly Drinker
7.581800E-01
Non Drinker-vs-Occasional Drinker
1.492220E-02
Non Drinker-vs-Social Drinker
1.943640E-01
Daily Drinker-vs-Weekly Drinker
4.784000E-01
Daily Drinker-vs-Occasional Drinker
1.285230E-01
Daily Drinker-vs-Social Drinker
5.711600E-01
Weekly Drinker-vs-Occasional Drinker
4.326400E-02
Weekly Drinker-vs-Social Drinker
2.304200E-01
Occasional Drinker-vs-Social Drinker
3.760400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.556760E-01
Normal-vs-Grade 2
4.284300E-02
Normal-vs-Grade 3
1.715840E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.996200E-01
Grade 1-vs-Grade 3
8.315400E-01
Grade 1-vs-Grade 4
1.556760E-01
Grade 2-vs-Grade 3
5.923900E-02
Grade 2-vs-Grade 4
4.284300E-02
Grade 3-vs-Grade 4
1.715840E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.321000E-01
Normal-vs-NonDiabetic
3.318800E-01
Diabetic-vs-NonDiabetic
5.435600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.344200E-01
Normal-vs-NoPancreatitis
2.913800E-01
Pancreatitis-vs-NoPancreatitis
8.201000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.695600E-01
Normal-vs-N1
2.901800E-01
N0-vs-N1
6.877800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.170400E-01
Normal-vs-TP53-NonMutant
5.299600E-01
TP53-Mutant-vs-TP53-NonMutant
6.730400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
